See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Surveys, Polls and Research
Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights)
NEW YORK, May 19, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Pharmaceutical Management of Obesity (Technical Insights)
The field of obesity management is seeing a lot of research and product development activities.This research service provides a detailed analysis of the technology developments and industry dynamics for obesity drugs. An evaluation of the adoption of obesity drugs has been discussed (regionwise) and some of the emerging areas of obesity research has also been highlighted. Some of the key industry drivers and challenges along with their market impact have been discussed.
Table of Contents
Executive Summary
Research Scope and Methodology 1
Research Scope and Segmentation1
Research Methodology 2
Research Overview 3
Introduction to Obesity and Anti-Obesity Drugs3
Key Findings and Analyst Insights 4
Technology Snapshot and Impact Analysis
Technology Snapshot 6
Anti-Obesity Drugs Classified on the Mode of Action6
Value Chain for Anti-Obesity Drugs 12
Assessment of Factors Influencing Adoption of Anti-Obesity Drugs 15
Market Impact of Key Drivers 15
Impact of Key Challenges and Restraints17
Regulatory Scenario 20
Diffusion of Innovations and Opportunity Evaluation
Diffusion of Innovation 23
Adoption of Anti-Obesity Drugs--North America 23
Adoption of Anti-Obesity Drugs--Europe and Asia Pacific 25
Overview of Partnerships and Alliances in the Industry 27
Opportunity Evaluation 31
Opportunity Strategy Evaluation of Anti-Obesity Drugs 31
Roadmap--Emerging Areas to Focus 34
Key Patents and Contacts
Key Patents 37
Issued Patents 37
Applied Patents40
Contacts 43
Corporate Contacts43
Academic Contacts44
D2A1 © 2011 Frost & Sullivan www frost com v
Pharmaceutical Management of Obesity
vi D2A1 © 2011 Frost & Sullivan www frost com
Decision Support Database
Decision Support Database Tables 46
Prevalence of Obese Population (2004-2014) 46
Pharmaceutical R&D Expenditure (2002-2012) 48
Total Healthcare Expenditure (2004-2014)50
To order this report:
Drug and Medication Industry: Pharmaceutical Management of Obesity (Technical Insights)
Drug and Medication Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Back to top
RELATED LINKS
http://www.reportlinker.com
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All That Glitters: The Ultimate Gold Report".